[Analgesia, sedation and neuromuscular block in pediatric intensive care units: present procedures and recent...

Area of Science:

• Pediatric Intensive Care Medicine
• Pharmacology
• Clinical Assessment

Context:

• Anxiolysis and pain management are critical in Pediatric Intensive Care Units (PICUs).
• Assessing sedation and analgesia in critically ill children presents significant challenges, especially when clinical examination is limited.
• Routine use of sedatives and analgesics requires careful titration and monitoring.

Purpose:

• To highlight the difficulties in assessing anxiolysis and pain in critically ill children.
• To discuss the common drug classes and strategies used for sedation and analgesia in PICUs.
• To emphasize the importance of appropriate drug selection and monitoring to prevent adverse events.

Summary:

• Sedation and analgesia in PICUs often involve combinations of benzodiazepines (e.g., Midazolam) with opioids (e.g., Morphine, Fentanyl).
• Other agents like Propofol, Clonidine, and Ketamine have specific indications, including brief procedures and withdrawal management.
• Neuromuscular blocking agents may be used adjunctively to support mechanical ventilation.
• Adverse sedation events are common, often linked to drug overdoses and interactions, particularly with polypharmacy (≥3 drugs).

Impact:

• Improved understanding of sedation and analgesia challenges in pediatric critical care.
• Guidance on drug selection and monitoring to optimize patient outcomes.
• Awareness of the risks associated with polypharmacy and the need for vigilant adverse event surveillance.